Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001393905-19-000201
Filing Date
2019-06-17
Accepted
2019-06-17 14:19:29
Documents
49
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ctbo_10q.htm 10-Q 288858
2 CERTIFICATION ctbo_ex311.htm EX-31.1 7645
3 CERTIFICATION ctbo_ex321.htm EX-32.1 2481
  Complete submission text file 0001393905-19-000201.txt   1761508

Data Files

Seq Description Document Type Size
4 ctbo-20181231.xml EX-101.INS 382337
5 ctbo-20181231.xsd EX-101.SCH 27007
6 ctbo-20181231_cal.xml EX-101.CAL 16018
7 ctbo-20181231_def.xml EX-101.DEF 50734
8 ctbo-20181231_lab.xml EX-101.LAB 113902
9 ctbo-20181231_pre.xml EX-101.PRE 107301
Mailing Address 2225 EAST BAYSHORE ROAD SUITE 200 PALO ALTO CA 94303
Business Address 2225 EAST BAYSHORE ROAD SUITE 200 PALO ALTO CA 94303 844-200-2826
Cantabio Pharmaceuticals Inc. (Filer) CIK: 0001550518 (see all company filings)

EIN.: 990373067 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54906 | Film No.: 19901098
SIC: 2834 Pharmaceutical Preparations